VYNE Therapeutics Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
VYNE on Nasdaq
Location
685 Route 202/206 N., Suite 301, Bridgewater, New Jersey

Insiders trading volume in the past year

VYNE Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Perceptive Advisors Llc 10%+ Owner $11.3 M Aug 16, 2021
AI Biotechnology LLC 10%+ Owner $2.55 M Nov 1, 2023
David Domzalski PRESIDENT AND CEO, Director $955 K Jul 1, 2024
Mutya Harsch Chief Legal Officer And Gc $286 K Jul 1, 2024
Andrew Saik Chief Financial Officer $266 K May 28, 2021
Iain Stuart Chief Scientific Officer $257 K Jul 1, 2024
Tyler Zeronda Chief Financial Officer $253 K Jul 1, 2024
Matthew T. Wiley Chief Commercial Officer $249 K Jun 30, 2021
Patrick G. Lepore Director $83.2 K +$50.8 K +157% Jan 1, 2024
Christine Borowski Director Jan 1, 2024
Elisabeth Sandoval Director Jan 1, 2024
Steven L. Basta Director Jan 1, 2024
Sharon Barbari Director Jan 1, 2024
Anthony D. Bruno Director Jan 1, 2024
Rex Bright Director Jul 19, 2021

Recent Insider Transactions by Companies or Individuals for VYNE Therapeutics Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership